Business
COVID-19 vaccine from China’s Sinovac 91.25 per cent effective, Turkey says after trial involving 7,000 volunteers – ABC News
A COVID-19 vaccine developed by China’s Sinovac Biotech is 91.25 per cent effective, according to interim data from a late-stage trial in Turkey.
A COVID-19 vaccine developed by China’s Sinovac Biotech has been 91.25 per cent effective, according to interim data from a late-stage trial in Turkey, a potentially much better result than reported from a separate trial of the vaccine in Brazil.
Key points:
- The Turkish trials began on September 14 and have included more than 7,000 volunteers
- Common adverse effects caused by the vaccine were fever, mild pain and slight fatigue
- 26 of the 29 people who were infected during the trial were given placebos
…
-
Noosa News11 hours agoShocking moment Bradley Donald Towle arrested after Bruce Hwy rampage and shooting on Sunshine coast
-
General12 hours agoNSW Police to provide update on Sydney woman’s kidnap from Bankstown home and killing
-
Noosa News19 hours agoMollie O’Callaghan admits to doubts, wins gold at Australian Open Swimming Championships
-
Noosa News17 hours agoFootage of man running with gun surfaces after deadly carjacking rampage near Aussie World on Queensland’s Sunshine Coast